SALT LAKE CITY--(BUSINESS WIRE)--Aug. 8, 2006--Myriad Genetics, Inc. (NASDAQ: MYGN - News) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
